Skinvisible, Inc. (SKVI) - Financial and Strategic SWOT Analysis Review

GlobalData, September 2011, Pages: 38

Skinvisible, Inc. (SKVI) - Financial and Strategic SWOT Analysis Review

Summary

Skinvisible, Inc. is a research and development pharmaceutical company that involved in developing topical polymer delivery vehicles to enhance formulated cosmetic and skincare products. It develops products for established brand manufacturers and marketers of Rx and OTC dermatological, medical, cosmetic and skincare products. The company's wholly owned subsidiary Skinvisible Pharmaceuticals, Inc. is engaged in developing enhanced, patented dermatology and health care products. The company licenses its patented Invisicare formulations to national and international dermatological, cosmetic, medical, skincare and consumer goods manufacturers and distributors. Skinvisible produces a variety of skincare products for private label clients. The company is headquartered at Las Vegas in Nevada, the US.

Skinvisible, Inc. Key Recent Developments

Apr 27, 2011 RHEI Pharmaceuticals Receives First European Approval For Hand Sanitizer
Feb 22, 2011 Skinvisible Receives Comprehensive Invisicare Patent For Canada
Jul 27, 2010 Skinvisibles Invisicare Patent Portfolio Strengthens
Jul 13, 2010 Skinvisible Licenses Invisicare Products For Us, China And Europe
Apr 13, 2010 Skinvisible Signs Development Agreement For Prescription Product For Women's Healthcare

This comprehensive SWOT profile of Skinvisible, Inc. provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

List of Tables
List of Figures
Section 1 - About the Company
Skinvisible, Inc. - Key Facts
Skinvisible, Inc. - Key Employees
Skinvisible, Inc. - Key Employee Biographies
Skinvisible, Inc. - Major Products and Services
Skinvisible, Inc. - History
Skinvisible, Inc. - Company Statement
Skinvisible, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Skinvisible, Inc. - Business Description
Skinvisible, Inc. - SWOT Analysis
SWOT Analysis - Overview
Skinvisible, Inc. - Strengths
Strength - Proprietary Invisicare Technology
Strength - Extensive Product Range
Strength - Agreements and Collaborations
Weakness - Limited Liquidity Position
Opportunity - Orphan Drug Designation
Opportunity - Rising Healthcare Expenditure in the US
Opportunity - Emerging Markets
Threat - Intense Competition
Threat - Tightening of the FDA’s Regulatory Oversight
Threat - Rapid Technological Change
Skinvisible, Inc. - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Skinvisible, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2005 to YTD 2011
Skinvisible, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2005 to YTD 2011
Skinvisible, Inc., Medical Equipment, Deals By Year, 2005 to YTD 2011
Skinvisible, Inc., Medical Equipment, Deals By Type, 2005 to YTD 2011
Skinvisible, Inc., Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 27, 2011: RHEI Pharmaceuticals Receives First European Approval For Hand Sanitizer
Feb 22, 2011: Skinvisible Receives Comprehensive Invisicare Patent For Canada
Jul 27, 2010: Skinvisibles Invisicare Patent Portfolio Strengthens
Jul 13, 2010: Skinvisible Licenses Invisicare Products For Us, China And Europe
Apr 13, 2010: Skinvisible Signs Development Agreement For Prescription Product For Womens Healthcare
Apr 13, 2010: Skinvisible Signs Development Agreement For Prescription Product For Women's Healthcare
Mar 23, 2010: Skinvisible Granted Patent For South Korea
Feb 11, 2010: Skinvisibles Safe4hours Promotion In Walgreens Expands
Jan 28, 2010: Skinvisible Licensee Receives Reorder From Walgreens
Jan 13, 2010: Skinvisible Licensee Announces Agreement With Walgreens
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Skinvisible, Inc., Key Facts
Skinvisible, Inc., Key Employees
Skinvisible, Inc., Key Employee Biographies
Skinvisible, Inc., Major Products and Services
Skinvisible, Inc., History
Skinvisible, Inc., Subsidiaries
Skinvisible, Inc., Key Competitors
Skinvisible, Inc., Ratios based on current share price
Skinvisible, Inc., Annual Ratios
Skinvisible, Inc., Interim Ratios
Skinvisible, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2005 to YTD 2011
Skinvisible, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2005 to YTD 2011
Skinvisible, Inc., Medical Equipment, Deals By Year, 2005 to YTD 2011
Skinvisible, Inc., Medical Equipment, Deals By Type, 2005 to YTD 2011
Skinvisible, Inc., Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Skinvisible, Inc., Performance Chart (2007 - 2010)
Skinvisible, Inc., Ratio Charts
Skinvisible, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2005 to YTD 2011
Skinvisible, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2005 to YTD 2011
Skinvisible, Inc., Medical Equipment, Deals By Year, 2005 to YTD 2011
Skinvisible, Inc., Medical Equipment, Deals by Type, 2005 to YTD 2011

Noven Pharmaceuticals, Inc.
Apricus Bioscience Inc
Foamix Ltd.
Stiefel Laboratories, Inc.
Galderma Laboratories, LP
SkyePharma PLC
Dow Pharmaceutical Sciences Inc.

Customers who bought this item also bought

• Top Five Global Software Companies: Performance, Strategies and Competitive Analysis
• eBay - Strong Execution
• Apple, Inc. - Strategies, Financial Outlook and Competitive Benchmark Analysis
• Scientific Games Corporation - Company Analysis
• Hewlett-Packard Company - Strategies, Financial Outlook and Competitive Benchmark Analysis
• Amazon - Point of Realization in 2013?
• Ixia - Company Analysis
• SunGard - Profile - US
• Insight into Samsung Electronics' Notebook PC Business Model
• US - Accenture - Company Profile